Nanalysis arranges $2.5-million private placement

Executive Summary

• Nanalysis Scientific Corp. announced a non-brokered private placement of up to 16,666,667 units at $0.15 per unit, raising up to $2.5 million in gross proceeds.
• Net proceeds are designated for debt reduction.
• Each unit includes one common share and a warrant to purchase half a share at $0.20, with a two-year term and an acceleration clause if the share price hits $0.30 for 10 consecutive days.

Key Details

• Transaction Structure: Non-brokered private placement of up to 16,666,667 units.
• Price: $0.15 per unit.
• Gross Proceeds: Up to $2,500,000.
• Use of Proceeds: Debt reduction.
• Unit Composition: Each unit consists of one common share and one-half of one common share purchase warrant.
• Warrant Terms:
  • Exercise Price: $0.20 per share.
  • Expiry: Two years from the closing date.
  • Acceleration Provision: If the closing price on the TSX Venture Exchange equals or exceeds $0.30 for any 10 consecutive trading days, the company may accelerate the warrant expiry to 30 days after notice/announcement. Unexercised warrants will automatically expire without compensation.
• Closing Conditions: Subject to TSX Venture Exchange acceptance and customary closing conditions.
• Tranches: The offering may close in one or more tranches.
• Initial Closing Date: Anticipated on or about December 15, 2025.
• Hold Period: Statutory hold period of four months and one day from the date of issue.

Notable Quotes

• None provided in the text.